# Mass General Brigham Neuroscience Institute

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/mass-general-brigham-neuroscience-institute
Canonical HTML page: https://getbiobrief.com/entity/mass-general-brigham-neuroscience-institute

## Recent coverage (1 stories)

### p-tau217 Blood Test Predicts 78% 10-Year Alzheimer Risk, Trial Enrichment Key
2026-07-25 04:21:29 · Sentiment: Very Bullish · Impact: 7/10 · Sources: 2

The p-tau217 blood test’s ability to identify cognitively healthy adults with up to 78% ten-year risk of cognitive decline offers pharma a powerful tool to enrich Alzheimer prevention trials, potentially accelerating drug development and reducing costs.
Full story: https://getbiobrief.com/story/p-tau217-blood-test-trial-enrichment-78-percent-risk

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.